Matthew A Muller1, Todd Belcik1, James Hodovan1, Koya Ozawa1, Eran Brown1, Jeffry Powers2, Paul S Sheeran2, Jonathan R Lindner3. 1. Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. 2. Philips Ultrasound, Bothell, Washington. 3. Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon. Electronic address: lindnerj@ohsu.edu.
Abstract
BACKGROUND: Cavitation of microbubble contrast agents with ultrasound produces shear-mediated vasodilation and an increase in tissue perfusion. We investigated the influence of the size of the cavitation volume by comparing flow augmentation produced by two-dimensional (2D) versus three-dimensional (3D) therapeutic ultrasound. We also hypothesized that cavitation could augment flow beyond the ultrasound field through release of vasodilators that are carried downstream. METHODS: In 11 rhesus macaques, cavitation of intravenously administered lipid-shelled microbubbles was performed in the proximal forearm flexor muscles unilaterally for 10 min. Ultrasound cavitation (1.3 MHz, 1.5 MPa peak negative pressure) was performed with 2D or 3D transmission with beam elevations of 5 and 25 mm, respectively, and pulsing intervals (PIs) sufficient to allow complete postdestruction refill (5 and 12 sec for 2D and 3D, respectively). Contrast ultrasound perfusion imaging was performed before and after cavitation, using multiplane assessment within and beyond the cavitation field in 1.5-cm increments. Cavitation in the hindlimb of mice using 2D ultrasound at a PI of 1 or 5 sec was performed to examine microvascular flow changes from cavitation in only arteries versus the microcirculation. RESULTS: In primates, the degree of muscle flow augmentation in the center of the cavitation field was similar for 2D and 3D conditions (five- to sixfold increase for both, P < .01 vs baseline). The spatial extent of flow augmentation was only modestly greater for 3D cavitation because of an increase in perfusion with 2D transmission that was detected outside of the cavitation field. In mice, cavitation in the microvascular compartment (PI 5 sec) produced the greatest degree of flow augmentation, yet cavitation in the arterial compartment (PI 1 sec) still produced a three- to fourfold increase in flow (P < .001 vs control). The mechanism for flow augmentation beyond the cavitation zone was investigated by in vitro studies that demonstrated cavitation-related release of vasodilators, including adenosine triphosphate and nitric oxide, from erythrocytes and endothelial cells. CONCLUSIONS: Compared with 2D transmission, 3D cavitation of microbubbles generates a similar degree of muscle flow augmentation, possibly because of a trade-off between volume of cavitation and PI, and only modestly increases the spatial extent of flow augmentation because of the ability of cavitation to produce conducted effects beyond the ultrasound field.
BACKGROUND: Cavitation of microbubble contrast agents with ultrasound produces shear-mediated vasodilation and an increase in tissue perfusion. We investigated the influence of the size of the cavitation volume by comparing flow augmentation produced by two-dimensional (2D) versus three-dimensional (3D) therapeutic ultrasound. We also hypothesized that cavitation could augment flow beyond the ultrasound field through release of vasodilators that are carried downstream. METHODS: In 11 rhesus macaques, cavitation of intravenously administered lipid-shelled microbubbles was performed in the proximal forearm flexor muscles unilaterally for 10 min. Ultrasound cavitation (1.3 MHz, 1.5 MPa peak negative pressure) was performed with 2D or 3D transmission with beam elevations of 5 and 25 mm, respectively, and pulsing intervals (PIs) sufficient to allow complete postdestruction refill (5 and 12 sec for 2D and 3D, respectively). Contrast ultrasound perfusion imaging was performed before and after cavitation, using multiplane assessment within and beyond the cavitation field in 1.5-cm increments. Cavitation in the hindlimb of mice using 2D ultrasound at a PI of 1 or 5 sec was performed to examine microvascular flow changes from cavitation in only arteries versus the microcirculation. RESULTS: In primates, the degree of muscle flow augmentation in the center of the cavitation field was similar for 2D and 3D conditions (five- to sixfold increase for both, P < .01 vs baseline). The spatial extent of flow augmentation was only modestly greater for 3D cavitation because of an increase in perfusion with 2D transmission that was detected outside of the cavitation field. In mice, cavitation in the microvascular compartment (PI 5 sec) produced the greatest degree of flow augmentation, yet cavitation in the arterial compartment (PI 1 sec) still produced a three- to fourfold increase in flow (P < .001 vs control). The mechanism for flow augmentation beyond the cavitation zone was investigated by in vitro studies that demonstrated cavitation-related release of vasodilators, including adenosine triphosphate and nitric oxide, from erythrocytes and endothelial cells. CONCLUSIONS: Compared with 2D transmission, 3D cavitation of microbubbles generates a similar degree of muscle flow augmentation, possibly because of a trade-off between volume of cavitation and PI, and only modestly increases the spatial extent of flow augmentation because of the ability of cavitation to produce conducted effects beyond the ultrasound field.
Authors: Matthew A Muller; Aris Xie; Yue Qi; Yan Zhao; Koya Ozawa; Misty Noble-Vranish; Jonathan R Lindner Journal: Ultrasound Med Biol Date: 2020-06-08 Impact factor: 2.998
Authors: J Todd Belcik; Brian H Mott; Aris Xie; Yan Zhao; Sajeevani Kim; Nathan J Lindner; Azzdine Ammi; Joel M Linden; Jonathan R Lindner Journal: Circ Cardiovasc Imaging Date: 2015-04 Impact factor: 7.792
Authors: Meera Sridharan; Shaquria P Adderley; Elizabeth A Bowles; Terrance M Egan; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague Journal: Am J Physiol Heart Circ Physiol Date: 2010-07-09 Impact factor: 4.733
Authors: Wilson Mathias; Jeane M Tsutsui; Bruno G Tavares; Agostina M Fava; Miguel O D Aguiar; Bruno C Borges; Mucio T Oliveira; Alexandre Soeiro; Jose C Nicolau; Henrique B Ribeiro; Hsu Po Chiang; João C N Sbano; Abdulrahman Morad; Andrew Goldsweig; Carlos E Rochitte; Bernardo B C Lopes; José A F Ramirez; Roberto Kalil Filho; Thomas R Porter Journal: J Am Coll Cardiol Date: 2019-03-17 Impact factor: 24.094
Authors: J Todd Belcik; Brian P Davidson; Aris Xie; Melinda D Wu; Mrinal Yadava; Yue Qi; Sherry Liang; Chae Ryung Chon; Azzdine Y Ammi; Joshua Field; Leanne Harmann; William M Chilian; Joel Linden; Jonathan R Lindner Journal: Circulation Date: 2017-02-07 Impact factor: 29.690
Authors: Robert J Siegel; Valentina N Suchkova; Takashi Miyamoto; Huai Luo; Raymond B Baggs; Yoram Neuman; Michael Horzewski; Veijo Suorsa; Sergio Kobal; Todd Thompson; Debra Echt; Charles W Francis Journal: J Am Coll Cardiol Date: 2004-10-06 Impact factor: 24.094
Authors: Federico Moccetti; Todd Belcik; Yllka Latifi; Aris Xie; Koya Ozawa; Eran Brown; Brian P Davidson; William Packwood; Azzdine Ammi; Sabine Huke; Jonathan R Lindner Journal: J Am Soc Echocardiogr Date: 2020-06-10 Impact factor: 5.251
Authors: Matthew A Muller; James Hodovan; Koya Ozawa; Matthew W Hagen; Theodore R Hobbs; John Templon; Yan Zhao; John A Kaufman; Jonathan R Lindner Journal: Ultrasound Med Biol Date: 2022-08-05 Impact factor: 3.694